Clinical Trial Update: Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on heparin-binding protein in acute respiratory failure patients treated with filgrastim (G-CSF); the Phase 2/3 program is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Respiratory Failure

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Acute Respiratory Failure, Critically Ill | Phase 2, Phase 3 | Status: COMPLETED